Hallucinations in Parkinson's disease: a follow-up study

Movement Disorders : Official Journal of the Movement Disorder Society
Anne Doé de MaindrevilleFlorence Mahieux

Abstract

To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1-year period, and identify factors predictive of the onset of hallucinations in patients who were hallucination-free at baseline, 141 unselected outpatients with PD were evaluated prospectively for a set of demographic, clinical, and therapeutic variables and the presence of hallucinations during the previous 3 months. Patient groups were compared with nonparametric tests, and logistic regression was applied to significant data. Follow-up data were available for 127 patients. The hallucination prevalence rates (%) at the first and second evaluation were, respectively, 41.7 and 49.6 for hallucinations of all types (NS), 29.1 and 40.2 for minor hallucinations (i.e., presence or passage hallucinations, and illusions) (P = 0.02), 22.8 and 21.2 for formed visual hallucinations (NS), and 8.7 and 8.7 for auditory hallucinations (NS). Hallucinations rarely started or ceased during the study. The most labile forms were minor hallucinations, which developed in 20% of patients and ceased in 9%. During follow-up, 15% of patients started to hallucinate. Three factors, all present at the first evaluation, independently predicted the onset of hallucinati...Continue Reading

References

Nov 3, 1998·Brain : a Journal of Neurology·M Manford, F Andermann
Feb 16, 2000·Psychiatry Research·A P Weiss, S Heckers
Mar 29, 2000·Brain : a Journal of Neurology·G FénelonM Ziégler
Jun 1, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·J Barnes, A S David
Jun 1, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·S HolroydG F Wooten
Jul 24, 2001·International Journal of Geriatric Psychiatry·C Murgatroyd, R Prettyman
Jun 11, 2003·Neurology·S A FactorUNKNOWN Parkinson Study Group
Jul 1, 1995·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Suzanne Holroyd, Adrienne Sheldon-Keller

❮ Previous
Next ❯

Citations

Jul 7, 2005·Journal of Neurology·Spiridon Papapetropoulos, D C Mash
Apr 3, 2007·Journal of Neurology·Günes KiziltanEthem Erginöz
Sep 20, 2008·Journal of Neurology·Guido AlvesJan Petter Larsen
Feb 5, 2011·Journal of Neurology·Michael OberholzerClaudio L Bassetti
Mar 20, 2012·Acta neurologica Belgica·Marina SvetelVladimir Kostić
Jun 6, 2009·Nature Reviews. Neurology·Nico J DiederichChristopher G Goetz
Dec 22, 2012·International Journal of Epidemiology·Meike KastenChristine Klein
Jan 6, 2012·The Neurologist·Oscar Bernal-PachecoHubert H Fernandez
Dec 7, 2006·Dementia and Geriatric Cognitive Disorders·Timothy A CrowellMichael Mullan
Mar 29, 2007·Dementia and Geriatric Cognitive Disorders·Inga LiepeltDaniela Berg
Apr 20, 2011·Dementia and Geriatric Cognitive Disorders·Kurt A Jellinger, Johannes Attems
Jul 31, 2008·Drugs & Aging·Laura B Zahodne, Hubert H Fernandez
Jul 10, 2010·The International Journal of Neuroscience·Jim BarnesKsenija Maravic
Dec 7, 2007·Expert Review of Neurotherapeutics·Marco OnofrjLaura Bonanni
Dec 10, 2015·Expert Opinion on Drug Safety·Roberto CeravoloUbaldo Bonuccelli
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
Jun 28, 2012·Neurobiology of Disease·I FerrerA Martínez
Sep 28, 2010·The American Journal of Geriatric Pharmacotherapy·Marty L Eng, Timothy E Welty
Sep 11, 2009·Journal of the Neurological Sciences·Gilles Fénelon, Guido Alves
Mar 10, 2009·General Hospital Psychiatry·Hal A Droogleever FortuynSebastiaan Overeem
Sep 26, 2015·Journal of Parkinson's Disease·Dag Aarsland, Milica Gregoric Kramberger
Jul 20, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Claudio PacchettiGiuseppe Nappi
Nov 21, 2007·International Journal of Geriatric Psychiatry·Nico J DiederichChristopher G Goetz
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Gabriella SantangeloPaolo Barone
Sep 1, 2006·Acta Neurologica Scandinavica·G BenbirE Erginöz
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Hubert H FernandezChristopher G Goetz
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Cynthia L Comella
Oct 18, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Elena SinforianiClaudio Pacchetti
Feb 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Bernard RavinaChristopher Goetz
Jun 30, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Stewart A FactorHaydeh Payami
May 20, 2011·CNS Neuroscience & Therapeutics·Lothar BurghausNico J Diederich
Jun 30, 2006·Journal of the Neurological Sciences·M OnofrjA Thomas
Jan 15, 2015·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Jacopo Vittoriano BizzarriHans Peter Kapfhammer
May 3, 2014·Parkinsonism & Related Disorders·Lorenzo KiferleUbaldo Bonuccelli
Aug 24, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Hee Kyung ParkSun Ju Chung
Jan 10, 2017·Journal of Geriatric Psychiatry and Neurology·Alana J MullerSimon J G Lewis
Jan 22, 2017·Journal of the Neurological Sciences·Karen Frei, Daniel D Truong
Mar 9, 2017·Bulletin of the Menninger Clinic·Muhammad Adnan KhanHassaan Tohid
Aug 11, 2018·Journal of Clinical Psychopharmacology·Brandon J DeluccaJonathan T Stewart
Jun 5, 2019·Expert Review of Clinical Pharmacology·Kelly E LyonsStuart Isaacson
Apr 24, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Dag AarslandDaniel Weintraub

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.